Evidence map›Paper›PMID 32002593›Full record

Trial reportIntensive care medicine2020

Intraosseous versus intravenous administration of adrenaline in patients with out-of-hospital cardiac arrest: a secondary analysis of the PARAMEDIC2 placebo-controlled trial.

Jerry P Nolan, Charles D Deakin, Chen Ji, Simon Gates, Andy Rosser, Ranjit Lall, Gavin D Perkins

Open access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 7 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 7 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Improving vasopressor use in cardiac arrest.Critical care (London, England) · 2023
    Review
  19. Article
  20. Drugs for advanced life support.Intensive care medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jerry P NolanWarwick Clinical Trials Unit, University of Warwick, Coventry, CV4 7AL, UK. paramedictrial@warwick.ac.uk.ORCID 0000-0003-3141-3812
Charles D DeakinSouth Central Ambulance Service NHS Foundation Trust, Otterbourne, SO21 2RU, UK.
Chen JiWarwick Clinical Trials Unit, University of Warwick, Coventry, CV4 7AL, UK.
Simon GatesCancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, B15 2TT, UK.
Andy RosserWest Midlands Ambulance Service University NHS Foundation Trust, Brierley Hill, DY5 1LX, West Midlands, UK.
Ranjit LallWarwick Clinical Trials Unit, University of Warwick, Coventry, CV4 7AL, UK.
Gavin D PerkinsWarwick Clinical Trials Unit, University of Warwick, Coventry, CV4 7AL, UK.
University of Warwick · GBCancer Research UK Clinical Trials Unit · GBEast Midlands Ambulance Service NHS Trust · GBRoyal United Hospital · GBSouth Western Ambulance Service NHS Foundation Trust · GB

Funding

Department of Health 12/127/126Health Technology Assessment Programme 12/127/126
6 · The paper itself

Abstract

purposeTo compare the effectiveness of the intravenous (IV) and intraosseous (IO) routes for drug administration in adults with a cardiac arrest enrolled in the Pre-Hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug Administration in Cardiac Arrest (PARAMEDIC2) randomised, controlled trial.

methodsPatients were recruited from five National Health Service Ambulance Services in England and Wales from December 2014 through October 2017. Patients with an out-of-hospital cardiac arrest who were unresponsive to initial resuscitation attempts were randomly assigned to 1 mg adrenaline or matching placebo. Intravascular access was established as soon as possible, and IO access was considered if IV access was not possible after two attempts.

resultsAmong patients with out-of-hospital cardiac arrest, 3631 received adrenaline and 3686 received placebo. Amongst these, 1116 (30.1%) and 1121 (30.4%) received the study drug via the IO route. The odds ratios were similar in the IV and IO groups for return of spontaneous circulation (ROSC) at hospital handover [adjusted odds ratio (aOR) 4.07 (95% CI 3.42-4.85) and (aOR 3.98 (95% CI 2.86-5.53), P value for interaction 0.90]; survival to 30 days [aOR 1.67 (1.18-2.35) versus 0.9 (0.4-2.05), P = 0.18]; and favourable neurological outcome [aOR 1.39 (0.93-2.06) versus 0.62 (0.23-1.67), P = 0.14].

conclusionThere was no significant difference in treatment effect (adrenaline versus placebo) on ROSC at hospital handover between drugs administered by the intraosseous route or by the intravenous route. We could not detect any difference in the treatment effect between the IV and IO routes on the longer term outcomes of 30-day survival or favourable neurological outcome at discharge (ISRCTN73485024).

Indexed as

Cardiopulmonary ResuscitationEmergency Medical ServicesOut-of-Hospital Cardiac ArrestAdministration, IntravenousAdultEnglandEpinephrineHumansState MedicineWalesEpinephrineAdrenalineCardiac arrestCardiopulmonary resuscitationIntraosseousIntravenous

Identifiers

PMID32002593
OpenAlexW3004343084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.